Data / Form D filings / Aperta Biosciences, LLC
Aperta Biosciences, LLC: Form D filing
Aperta Biosciences, LLC, a pharmaceuticals company in Saint Louis, MO, filed a Form D with the SEC in 2018. The latest, on November 26, 2018, reports $175,000 sold of a $750,000 offering to 2 investors.
Find out what Aperta Biosciences, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 S. SARAH STREET, Saint Louis, MO, 63108
- Phone
- (314) 272-2645
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1758162
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 26, 2018 | New notice | $750,000 | $175,000 | $575,000 | 2 | Nov 14, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frameshift, LLC Frameshift, LLC | Director, Promoter | |
| Carlos Santos | Executive Officer, Director, Promoter | |
| Jonathan Feldmann | Executive Officer, Director, Promoter | |
| Forrest Cox | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in Missouri that filed recently
- Immunophotonics, Inc. $10.1 million · Sep 4, 2026
Every Form D from the week of Nov 26, 2018 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aperta Biosciences, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.